Therapies for adrenal insufficiency

Expert Opinion on Therapeutic Patents

Volumn 17, Issue 11, 2007, Pages 1323-1329

  Andrioli, Massimiliano ^a   Giraldi, Francesca Pecori ^a   De Martin, Martina ^a   Cavagnini, Francesco ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Adrenal crisis; Adrenal insufficiency; Dehydroepiandrosterone; Fludrocortisone; Glucocorticoid; Replacement therapy

Indexed keywords

ALDOSTERONE; ANTIANDROGEN; BIOCHEMICAL MARKER; CHOLESTEROL; CORTICOSTEROID; CORTISONE; CORTISONE ACETATE; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; HYDROCORTISONE ACETATE; LIPID; METHYLPREDNISOLONE; MINERALOCORTICOID; POTASSIUM; PRASTERONE; PRASTERONE SULFATE; PREDNISONE; STEROID;

ADDISON DISEASE; ADRENAL CORTEX INSUFFICIENCY; ADRENAL INSUFFICIENCY; BEDTIME DOSAGE; BLOOD PRESSURE REGULATION; BONE METABOLISM; CARDIOVASCULAR DISEASE; CHOLESTEROL METABOLISM; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; CONTINUOUS INFUSION; CORTICOSTERONE RELEASE; DELIVERY; DIASTOLIC BLOOD PRESSURE; DOSAGE SCHEDULE COMPARISON; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG MONITORING; DRUG SAFETY; DRUG STRUCTURE; EDEMA; EDITORIAL; EVIDENCE BASED MEDICINE; EYE DISEASE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART FAILURE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; INFECTION; INJURY; INSULIN SENSITIVITY; INTRAOCULAR PRESSURE; LIPID METABOLISM; LONG TERM CARE; LOW DRUG DOSE; MENTAL DISEASE; MORNING DOSAGE; MORTALITY; NEUROLOGIC DISEASE; PATIENT COMPLIANCE; PERIPHERAL EDEMA; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PREGNANCY; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; RISK BENEFIT ANALYSIS; SIDE EFFECT; SLEEP DISORDER; SURGICAL STRESS; SYSTOLIC BLOOD PRESSURE; UNSPECIFIED SIDE EFFECT;

EID: 36549069274     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.17.11.1323     Document Type: Editorial

References (19)

1. ARLT W, ALLOIO B: Adrenal insufficiency. Lancet (2003) 361:1881-1893.
2. ANDRIOLI M, PECORI GIRALDI F, CAVAGNINI F: Isolated corticotrophin deficiency. Pituitary (2006) 9:289-295.
3. SPEISER P, WHITE P: Congenital adrenal hyperplasia. N. Engl. J. Med. (2003) 349:776-788.
4. MAH PM, JENKINS RC, ROSTAMI-HODJEGAN A et al.: Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin. Endocrinol. (2004) 61:367-375.
5. CROWN A, LIGHTMAN S: Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clin. Endocrinol. (2005) 63:483-492.
6. PECORI GIRALDI F, FATTI L, CAVAGNINI F: Isolated corticotrophin deficiency presenting with pericardial effusion. J. Endocrinol. Invest. (2005) 28:831-833.
7. VALERO MA, LEON M, RUIZ VALDEPENAS M et al.: Bone density and turnover in Addison's disease: effect of glucocorticoid treatment. Bone Miner. (1994) 26:9-17.
8. WICHERS M, SPRINGER W, BIDLINGMAIER F et al.: The influence of hydrocortisone substitution on the quality of life and parameters of bone metabolism in patients with secondary hyocortisolism. Clin. Endocrinol. (1999) 50:759-765.
9. THOMSEN AF, KVIST TK, ANDERSEN PK et al.: The risk of affective disorders in patients with adrenocortical insufficiency. Psychoneuroendocrinology (2006) 31:614-622.
10. GARCIA-BORREGUERO D, WEHR TA, LARROSA O et al.: Glucocorticoid replacement is permissive for rapid eye movement sleep and sleep consolidation in patients with adrenal insufficiency. J. Clin. Endocrinol. Metab. (2000) 85:4201-4206.
11. LI VOON CHONG JS, SEN J, JOHNSON Z et al.: Hydrocortisone replacement dosage influences intraocular pressure in patients with primary and secondary hypocortisolism. Clin. Endocrinol. (2001) 54:267-271.
12. NICHOLSON G, BURRIN JM, HALL GM: Peri-operative steroid supplementation. Anesthesia (1998) 53:1091-1104.
13. HAHNER S, ALLOIO B: Management of adrenal insufficiency indifferent clinical settings. Expert Opin. Pharmacother. (2005) 6(14):2407-2417.
14. FEEK CM, RATCLIFFE JG, SETH J et al.: Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement. Clin. Endocrinol. (1981) 14:451-458.
15. PUTIGNANO P, TOJA P, DUBINI A: Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome. J. Clin. Endocrinol. Metab. (2003) 88:4153-4157.
16. FLAD TM, CONWAY JD, CUNNINGHAM SK et al.: The role of plasma renin activity in evaluating the adequacy of mineralocorticoid replacement in primary adrenal insufficiency. Clin. Endocr. (1996) 45:529-534.
17. HUNT PJ, GURNELL EM, HUPPERT FA et al.: Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J. Clin. Endocrinol. Metab. (2000) 85:4650-4656.
18. LIBÈ R, BARBETTA L, DALL'ASTA C et al.: Effects of DHEA supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism. Clin. Endocrinol. (2004) 27:736-741.
19. MERKE DP, BORNSTEIN S: Congenital adrenal hyperplasia. Lancet (2005) 365:2125-2136.